CCL2 and non-small cell lung carcinoma: Treatment of mice with a neutralizing antibody to MCP-1 reduces the growth and metastasis of non-small-cell lung carcinoma [6]; stable knockdown of MCP-1 in MDA-MB-231 mammary carcinoma cells reduces their metastasis in vivo [7].